EARNINGS AND TRADING: Scancell gets FDA clearance for phase 3 trial
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 0.205p on 18-03-2026 at 13:50:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.21p |
| Sell | 0.20p |
| Last Trade: | Buy 150,000.00 at 0.21p |
| Day's Volume: | 250,000 |
| Last Close: | 0.205p |
| Open: | 0.205p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.205p - 0.205p |
| 52wk Range: | 0.18p - 0.286p |
| Market Capitalisation: | £4.41m |
| VWAP: | 0.21p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 150,000 | 0.21p | Ordinary |
10:38:45 - 18-Mar-26 |
| Buy* | 100,000 | 0.21p | Ordinary |
08:48:09 - 18-Mar-26 |
| Buy* | 5,238 | 0.21p | Ordinary |
16:26:27 - 17-Mar-26 |
| Buy* | 15,992 | 0.21p | Ordinary |
16:15:35 - 17-Mar-26 |
| Buy* | 13,047 | 0.21p | SI Trade |
16:15:35 - 17-Mar-26 |
| Buy* | 46 | 0.21p | SI Trade |
16:15:35 - 17-Mar-26 |
| Buy* | 2,897 | 0.21p | SI Trade |
16:15:35 - 17-Mar-26 |
| Buy* | 498,503 | 0.206p | Ordinary |
15:46:41 - 17-Mar-26 |
| Buy* | 21,868 | 0.2058p | Ordinary |
14:59:41 - 17-Mar-26 |
| Sell* | 100,000 | 0.202p | Ordinary |
14:04:23 - 17-Mar-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Jan 2026 7:00 am | RNS | Ox-1 Addiction Programme Update |
| 5th Jan 2026 7:00 am | RNS | Key Ox-1 milestone & notice of investor webinar |
| 18th Dec 2025 7:00 am | RNS-R | Potential of Preclinical Program in Mental Fatigue |
| 3rd Dec 2025 7:00 am | RNS | Half-year Financial Report |
| 26th Nov 2025 7:00 am | RNS-R | Marking Addiction Awareness Week |
| 24th Nov 2025 7:00 am | RNS | Notice of Results |
| 3rd Nov 2025 7:00 am | RNS | Ox-1 Programme Achieves Manufacturing Milestone |
| 16th Oct 2025 4:45 pm | RNS | Holding(s) in Company |
| 16th Oct 2025 4:45 pm | RNS | Director/PDMR Shareholding |
| 10th Oct 2025 7:00 am | RNS-R | World Mental Health Day & Q4 Conference Schedule |